🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anda Vlad

National Institutes of Health

ORCID: 0000-0001-5266-9695

Also affiliated with University of Pittsburgh, Office of the Director, Magee-Womens Research Institute, National Cancer Institute, Spitalul Clinic de Psihiatrie Alexandru Obregia

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Release of Interferon-β (IFN-β) from Probiotic Limosilactobacillus reuteri-IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal Irradiation”.

Release of Interferon-β (IFN-β) from Probiotic Limosilactobacillus reuteri-IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal Irradiation

Cancers(2023)10.3390/cancers15061670
N/A
0.457DataRank · unranked
20 citations

Michael W. Epperly, Renee Fisher, Wen‐Chi Hou, Donna Shields, Jan‐Peter van Pijkeren +11 more

High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition

npj Precision Oncology(2021)10.1038/s41698-021-00242-8
N/A
0DataRank · unranked
56 citations

Ahmed Soliman, Amy Joehlin‐Price, Peter G. Rose, Anda Vlad, Robert P. Edwards +2 more

Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic Lactobacillus-reuteri Engineered to Deliver Interleukin-22

International Journal of Molecular Sciences(2022)10.3390/ijms23105616
N/A
0DataRank · unranked
33 citations

Michael W. Epperly, Amitava Mukherjee, Renee Fisher, Donna Shields, Hong Wang +14 more

Longitudinal Modulation of Loco-Regional Immunity in Ovarian Cancer Patients Receiving Intraperitoneal Chemotherapy

Cancers(2022)10.3390/cancers14225647
N/A
0DataRank · unranked
5 citations

Mary Strange, Yusi Fang, Ibrahim Uygun, Lixin Zhang, George C. Tseng +4 more

Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2254
N/A
0DataRank · unranked
25 citations

Santiago Panesso-Gómez, Jaynish S. Shah, Tonge Ebai, Qi Jiang, Ece Gümüşoğlu-Acar +6 more

Data from Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity

(2023)10.1158/1078-0432.c.6532676
N/A
0DataRank · unranked
0 citations

Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more

Data from Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity

(2023)10.1158/1078-0432.c.6532676.v1
N/A
0DataRank · unranked
0 citations

Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more

Immunotherapy Advances for Epithelial Ovarian Cancer

Cancers(2020)10.3390/cancers12123733
N/A
0DataRank · unranked
39 citations

Julia Knight, Mackenzy Radolec, Ronald J. Buckanovich, Robert P. Edwards, Anda Vlad +1 more

Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancer

Disease Models & Mechanisms(2025)10.1242/dmm.052177
N/A
0DataRank · unranked
0 citations

Yusi Fang, Ibrahim Uygun, Danyang Li, Mary Strange, Syed I. A. Zaidi +12 more